May 26, 2023 / NTS GMT
Presentation
May 26, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* René C. Goehrum
BioSyent Inc. - Chairman, CEO & President
=====================
RenéC. Goehrum - BioSyent Inc. - Chairman, CEO & President
Hello and welcome to the Q1 2023 Results Presentation for BioSyent Inc. My name is René Goehrum, and I'm the President and CEO of the company.
After drawing your attention to our disclaimer regarding forward-looking statements, I'm going to dive into the presentation with a look first at a breakdown of our contributors to our sales in the first quarter of 2023. As we normally do, we've segmented this into Canadian Pharmaceutical, International Pharmaceutical and Legacy Business, and there's a couple of things I'd like to comment before I go down on a by-brand basis.
So what we saw in the Canadian Pharmaceutical business is strong end market demand growth, and that is a growth of shipments from our wholesale customers to retail pharmacy and to hospitals that was not
Q1 2023 Biosyent Inc Earnings Presentation Transcript
May 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers